SBTX
Silverback Therapeutics Inc
Price:  
5.87 
USD
Volume:  
116,700.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SBTX Relative Valuation

-467.0%
Upside

As of 2024-12-14, the Relative Valuation of Silverback Therapeutics Inc (SBTX) is (21.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.87 USD, the upside of Silverback Therapeutics Inc based on Relative Valuation is -467.0%.

The range of the Relative Valuation is (19.93) - (18.49) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 20.7x - 31.0x 25.8x
Forward P/E multiples 18.7x - 19.2x 19.0x
Fair Price (19.93) - (18.49) (21.55)
Upside -439.5% - -414.9% -467.0%
5.87 USD
Stock Price
(21.55) USD
Fair Price

SBTX Relative Valuation - Historical P/E Data

Date P/E